Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

The following is a summary of “Feasibility, Usability, and Pilot Efficacy Study of a Software-Enabled, Virtual Pulmonary ...

Vitamin D deficiency is strongly associated with an increased risk of severe acute exacerbations in patients with chronic ...

Behavioral cough suppression therapy may be effective in patients with refractory and unexplained chronic cough (RCC and UCC).

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...